NOAC-vs-ASA-in-ESUS-trial-results-published-in-NEJM

Trial results of Pradaxa ® vs ASA in ESUS published in NEJMFirst Phase III randomised clinical trial to compare dabigatran etexilate and acetylsalicylic acid (ASA)  No significant difference in recurrent stroke prevention after ESUSDabigatran showed no significant difference in major bleeding
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news